Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment

Recruiting now · Not applicable

Conditions studied: Dementia, Alzheimer Disease

In brief

The objective of the study is to investigate the clinical validity of tau-PET with \[18F\]RO948 vs. amyloid-PET in patients with Mild Cognitive Impairment (MCI) or mild dementia

Key facts

Study ID
NCT06618872
Run by
University Hospital, Geneva
People needed
120
Starts
2024-12-03
Expected to finish
2027-08-30
Last updated by the study team
2025-12-23

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.